Integrating anti-EGFR therapies in metastatic colorectal cancer.
about
Mechanisms underlying skin disorders induced by EGFR inhibitorsThe biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized careCombination of gefitinib and DNA methylation inhibitor decitabine exerts synergistic anti-cancer activity in colon cancer cellsEpidermal Growth Factor Receptor Cell Proliferation Signaling PathwaysPrimary and acquired resistance to biologic therapies in gastrointestinal cancers.Personalizing medicine for metastatic colorectal cancer: current developments.Colorectal carcinogenesis--update and perspectives.Multipoint Kras oncogene mutations potentially indicate mucinous carcinoma on the entire spectrum of mucinous ovarian neoplasms.Targeted therapies in colorectal cancer: the dos, don'ts, and future directionsMeta-analysis of the mutational status of circulation tumor cells and paired primary tumor tissues from colorectal cancer patients.EGFR in Tumor-Associated Myeloid Cells Promotes Development of Colorectal Cancer in Mice and Associates With Outcomes of Patients.Genotypic and phenotypic signatures to predict immune checkpoint blockade therapy response in patients with colorectal cancer.ADAM17 is required for EGF-R-induced intestinal tumors via IL-6 trans-signaling.
P2860
Q26745689-0D863B5B-FE26-488A-BD43-57A67CFED031Q28066460-A23A5CCC-CE5D-4594-B872-1E2A9B6A1229Q28539177-33450CC4-C44E-4816-8988-4E3BE7C4DBA0Q33737298-F88C4DAE-3DBE-43F8-90B0-7B3683F3EA12Q33895573-5500BAB4-CE47-4FBB-9486-B4C2E32BC5F1Q34036665-B66D598A-B1B1-4E4F-96CB-EF17AB3C9F3EQ34667352-7D1A9118-14F8-491A-B338-F0F1BEA20D33Q37696086-1B3ABD65-A83C-40F3-80D3-2778A97178A6Q39357003-FB8DB8D4-AAEF-44C0-84D7-F0604D5EF7EEQ43182172-F4049377-8925-47C2-A755-16046302B8A4Q49861198-52D239C2-CD2F-4898-91E3-AB5188830ABEQ52666692-2D1E5155-BB87-48ED-A07F-251AA411DC38Q52689175-C2238A23-6A8C-4ADF-A9F4-A57274751D7F
P2860
Integrating anti-EGFR therapies in metastatic colorectal cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Integrating anti-EGFR therapies in metastatic colorectal cancer.
@en
Integrating anti-EGFR therapies in metastatic colorectal cancer.
@nl
type
label
Integrating anti-EGFR therapies in metastatic colorectal cancer.
@en
Integrating anti-EGFR therapies in metastatic colorectal cancer.
@nl
prefLabel
Integrating anti-EGFR therapies in metastatic colorectal cancer.
@en
Integrating anti-EGFR therapies in metastatic colorectal cancer.
@nl
P2860
P1476
Integrating anti-EGFR therapies in metastatic colorectal cancer.
@en
P2093
Tanios Bekaii-Saab
P2860
P304
P356
10.3978/J.ISSN.2078-6891.2013.028
P577
2013-09-01T00:00:00Z